Delivery Order SPE2DB22D1106-SPE2DB24FFJF6

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $56K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $7,879.18 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,563,280,716 units of the drug Xarelto 20 mg tablets. The contract has an ultimate completion date of January 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division, valued at $999,999,999 and running through...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $4,721.08 firm fixed-price delivery order contract for the supply of 4,565,285,732 units of Xarelto 20 mg tablets. The contract has an ultimate completion date of July 30, 2024. Amerisourcebergen is the prime contractor, and the contract is not set aside. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The $31,355.64 contract is for the supply of Xarelto 20 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary...
This is a $11,292.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 mg tablets. The contract has an ultimate completion date of October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of...
This is a $12,249.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 20 mg tablets. It is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 90-count packages of the pharmaceutical drug Xarelto 20 mg tablets. The contract has a ceiling value of $1,503.32 and a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a $14,019.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division to supply XARELTO 20 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of critical pharmaceutical and medical supplies. As a major pharmaceutical distributor,...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Xarelto 20 mg tablets. The contract has a potential value of $3,315.36 and a completion date of February 29, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,355.85 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XARELTO 20 MG TABLET 90S, a prescription medication, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $19,892.16 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xarelto 20 mg tablets, a prescription medication, to support military treatment facilities and other government healthcare programs. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFJF6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $56,409.59 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565551169 - Xarelto 20 mg Tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and the ultimate completion date is August 23, 2024.

Generated 11/21/24, 9:13 AM